Wang, T., Zhang, K., Hu, P., Wan, Q., Han, F., Zhou, J., . . . Lv, N. (2017). Combination of dual serum fluorescence, AFP and hepatic function tests is valuable to identify HCC in AFP-elevated liver diseases. Oncotarget.
Stile di citazione ChicagoWang, Ting, Kun-He Zhang, Piao-Ping Hu, Qin-Si Wan, Fang-Li Han, Jian-Ming Zhou, De-Qiang Huang, e Nong-Hua Lv. "Combination of Dual Serum Fluorescence, AFP and Hepatic Function Tests Is Valuable to Identify HCC in AFP-elevated Liver Diseases." Oncotarget 2017.
Citazione MLAWang, Ting, et al. "Combination of Dual Serum Fluorescence, AFP and Hepatic Function Tests Is Valuable to Identify HCC in AFP-elevated Liver Diseases." Oncotarget 2017.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.